Semaglutide

Semaglutide is a GLP-1 receptor agonist medication FDA-approved for weight management (brand names Wegovy, Ozempic). It mimics a natural gut hormone that signals fullness, slows gastric emptying so you feel full longer, and reduces appetite at the brain level. Result: most patients lose 15% of body weight over 12 months when paired with nutrition and lifestyle support.

Most patients lose 1–2 lbs per week consistently once at therapeutic dose. Rate slows at month 6–9 as your body approaches a new set point. Total expected loss at 12 months: ~15% of starting body weight. First month is dose-finding (low dose, less weight loss), not rapid loss.

Both are GLP-1 medications. Semaglutide targets one receptor pathway (GLP-1). Tirzepatide targets two (GLP-1 and GIP), producing slightly greater weight loss in studies (~20% vs ~15%). Tirzepatide costs more. Both are effective; we'll discuss which fits your goals and budget at consultation.

Common: nausea (especially during dose increases—usually mild and transient), constipation or diarrhea, occasional vomiting, fatigue in first weeks, decreased appetite (the desired effect). Rare: pancreatitis (we screen for risk factors), gallbladder issues with rapid weight loss. Most side effects resolve as your body adjusts.

Weekly self-administered subcutaneous injection using a small needle (similar to insulin). We teach you the technique at your first visit. Injections take seconds, with rotating sites on the thigh, abdomen, or upper arm.

Starting at $215/month for compounded semaglutide including medication, supplies, and provider visits. Pricing increases with dose escalation. Initial labs: $150–$250. We use compounded versions to keep cost accessible vs. brand-name pricing.

Yes. We can prescribe with appropriate BMI (typically 27+ with comorbidities, or 30+ without) after evaluation. Our physician director reviews each case. We don't prescribe for patients who don't meet criteria or have contraindications—it's a medical decision.

Most patients who stop semaglutide see partial weight regain—the medication addresses ongoing appetite regulation. Long-term low-dose maintenance is common for sustaining results. Some patients can taper after building strong lifestyle habits. We discuss long-term planning from the start.

Sometimes yes for diabetes (Ozempic), often no for weight management (Wegovy). Coverage depends on your plan and diagnosis. We don't bill insurance directly but provide documentation you can submit for reimbursement attempts. For most patients, GLP-1 is out-of-pocket.

Contraindications include personal/family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome, pancreatitis history, severe gastroparesis, and pregnancy. We screen thoroughly before prescribing.

Comprehensive metabolic panel including lipids, A1c, kidney and liver function, thyroid panel, lipase. We monitor labs at 3 and 6 months after starting, then annually. If you have recent labs from primary care, bring them.

We provide nutrition guidance focused on adequate protein (preserving muscle during weight loss), hydration, fiber, and avoiding nutrient deficiencies during reduced calorie intake. Hyper-restrictive diets aren't necessary—semaglutide naturally reduces appetite.

Yes—resistance training (weights) is especially important. Rapid weight loss without resistance training causes significant muscle loss. Patients who lift weights 2–3x per week preserve more muscle and have better long-term results.

Initial consultation: medical history, lab review, treatment plan, prescription. Monthly visits during dose titration: weight check, side effect review, dose adjustment. Quarterly visits during maintenance. We're available between visits for questions.

Book a wellness consultation. We'll discuss your goals, review medical history and recent labs, evaluate appropriateness, and design a treatment plan with honest pricing. If semaglutide isn't right for you, we'll tell you. Call (806) 701-5840 or book online.

Semaglutide is typically administered once weekly through a simple injection. Your provider will guide you on proper dosing and treatment schedule.

Some patients may experience mild side effects such as nausea, bloating, constipation, diarrhea, or decreased appetite, especially during the beginning of treatment. Most side effects improve as the body adjusts.

Results vary from person to person, but many patients begin noticing changes within the first few weeks. With consistent treatment, healthy nutrition, and regular activity, significant weight loss may be achieved over time.

Semaglutide may be a good option for adults struggling with weight management or those looking for additional support in reaching their health goals. A consultation is recommended to determine if treatment is appropriate for your needs and medical history.

Semaglutide is a medication that helps regulate appetite and blood sugar levels by mimicking a natural hormone in the body called GLP-1. It helps you feel fuller longer, reduces cravings, and can support sustainable weight loss when combined with healthy lifestyle habits.